American tech executive and independent director
Oura has postponed its planned Nasdaq flotation due to uncertainty in the IPO market, while noting strong demand and continued revenue growth. The company remains profitable with growing subscription revenue and expanded health-tracking features, and says the delay is a strategic choice, not a signal of deteriorating fundamentals.